SCHEMBL340563

SCHEMBL340563

C=C(C)C(=O)NCCCOC(=O)C(C)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ACHE P22303 7/20 0.37
TSHR P16473 4/20 0.35
LMNA P02545 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA3 P07451 1/20 0.33
CA4 P22748 1/20 0.33
CA6 P23280 1/20 0.33
CA5A P35218 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
CA13 Q8N1Q1 1/20 0.33
CA14 Q9ULX7 1/20 0.33
CA5B Q9Y2D0 1/20 0.33
HPGD P15428 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL339532 0.90 MEN1 (0.46) ALDH1A1MEN1KMT2AACHETSHR
SCHEMBL2608199 0.83 ACHE (0.39) ALDH1A1ACHETSHR
SCHEMBL10388828 0.82 ACHE (0.41) ALDH1A1ACHETSHR
SCHEMBL2608172 0.82 ACHE (0.41) ALDH1A1ACHETSHR
SCHEMBL9421249 0.81 TSHR (0.55) ALDH1A1ACHETSHR
SCHEMBL167252 0.79 ALDH1A1 (0.51) ALDH1A1MEN1KMT2AACHETSHR
SCHEMBL1197607 0.79 ALDH1A1 (0.65) ALDH1A1KMT2ATSHRLMNAHPGD
SCHEMBL28294700 0.79 ACHE (0.39) ALDH1A1ACHETSHRLMNA
SCHEMBL339706 0.79 TSHR (0.38) ALDH1A1MEN1KMT2ATSHR
SCHEMBL24496157 0.78 ALDH1A1 (0.41) ALDH1A1MEN1KMT2AACHETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108367100-B Photoactivated preparation of hydrogels 奥塔哥创新有限公司 2022-03-22 CN disclosed
EP-3383447-B1 LIGHT-ACTIVATED PREPARATION OF HYDROGELS OTAGO INNOVATION LTD (NZ) 2021-06-23 EP disclosed
US-10995186-B2 Light-activated preparation of hydrogels OTAGO INNOVATION LIMITED (NZ) 2021-05-04 US disclosed
US-20180355127-A1 LIGHT-ACTIVATED PREPARATION OF HYDROGELS OTAGO INNOVATION LIMITED (NZ) 2018-12-13 US disclosed
EP-3383447-A1 LIGHT-ACTIVATED PREPARATION OF HYDROGELS Otago Innovation Limited (NZ) 2018-10-10 EP disclosed
WO-2017095240-A1 LIGHT-ACTIVATED PREPARATION OF HYDROGELS LIM SHEN KHOON (NZ) 2017-06-08 WO disclosed
US-8110220-B2 Temperature sensitive polymers UNIVERSITEIT UTRECHT (NL) 2012-02-07 US disclosed
US-20120015034-A1 TEMPERATURE SENSITIVE POLYMERS UNIVERSITEIT UTRECHT (NL) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015034-A1 TEMPERATURE SENSITIVE POLYMERS LCT, LDHA, LDHB ALDH1A1 235/4885MEN1 3434/4885KMT2A 2446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.